12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dexilant dexlansoprazole regulatory update

FDA approved a label change for Dexilant dexlansoprazole to state that no dose adjustment is necessary when the drug is given in combination with Plavix clopidogrel....

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >